Phosphatidylinositol containing lipidic particles reduces immunogenicity and catabolism of factor VIII in hemophilia a mice
about
Effects of replacement of factor VIII amino acids Asp519 and Glu665 with Val on plasma survival and efficacy in vivo.Soy phosphatidylinositol containing nanoparticle prolongs hemostatic activity of B-domain deleted factor VIII in hemophilia A mice.Targeting liposomes loaded with melphalan prodrug to tumour vasculature via the Sialyl Lewis X selectin ligand.Phosphatidylinositol induces fluid phase formation and packing defects in phosphatidylcholine model membranesPEGylation of a factor VIII-phosphatidylinositol complex: pharmacokinetics and immunogenicity in hemophilia A mice.A novel ovine ex vivo arteriovenous shunt model to test vascular implantability.Allometry of factor VIII and informed scaling of next-generation therapeutic proteins.Native-like aggregates of factor VIII are immunogenic in von Willebrand factor deficient and hemophilia a miceNonlinear pharmacokinetics of factor VIII and its phosphatidylinositol lipidic complex in hemophilia A mice.Downregulation of CD40 signal and induction of TGF-β by phosphatidylinositol mediates reduction in immunogenicity against recombinant human Factor VIIIGenetic risk factors for inhibitors in haemophilia A.Factor VIII associated with lipidic nanoparticles retains efficacy in the presence of anti-factor VIII antibodies in hemophilia A mice.Soy Phosphatidylinositol-Containing Lipid Nanoparticle Prolongs the Plasma Survival and Hemostatic Efficacy of B-domain-Deleted Recombinant Canine Factor VIII in Hemophilia A Dogs.An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia.
P2860
Q34099771-DD64F2BC-7B1D-4A0C-8BEC-C633FE1BB42FQ34283156-150E7B9A-E888-4045-AC0B-CCEA3FFC44E8Q35061731-5543E40B-8B82-48EB-93A9-F650C3E68DDCQ35645401-CAA0029E-8A7A-4B37-B90B-F6B36D7749FDQ35793113-EABD8D14-5FDF-4729-BA74-1E13249001B2Q35886902-499C31B6-A30B-488D-A79C-7912A7A13033Q36912731-728A240E-4023-436F-82C4-160C818AC106Q37174443-6142E3C0-032C-4F33-A82F-558D84A47630Q37686530-9135EB9D-E7DD-45A3-8322-EDA92295FF33Q37718280-3CB9414A-A8E4-4DCD-91EC-11C57F8C22C0Q38308196-6BC2635D-A4E2-41A0-BCA8-46B24D96CE19Q39600375-5220A1AD-824A-4C0E-938F-E5E8CCC02576Q42220577-671802E6-5780-4B41-A4B3-D6FBAE5059A9Q45874701-70F17FB0-06DA-426C-ACA1-1D084FAA1F92
P2860
Phosphatidylinositol containing lipidic particles reduces immunogenicity and catabolism of factor VIII in hemophilia a mice
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Phosphatidylinositol containin ...... ctor VIII in hemophilia a mice
@ast
Phosphatidylinositol containin ...... ctor VIII in hemophilia a mice
@en
type
label
Phosphatidylinositol containin ...... ctor VIII in hemophilia a mice
@ast
Phosphatidylinositol containin ...... ctor VIII in hemophilia a mice
@en
prefLabel
Phosphatidylinositol containin ...... ctor VIII in hemophilia a mice
@ast
Phosphatidylinositol containin ...... ctor VIII in hemophilia a mice
@en
P2093
P2860
P921
P1433
P1476
Phosphatidylinositol containin ...... ctor VIII in hemophilia a mice
@en
P2093
Aaron Peng
Robert M Straubinger
Sathy V Balu-Iyer
P2860
P2888
P304
P356
10.1208/S12248-010-9207-Z
P407
P577
2010-06-02T00:00:00Z
P5875
P6179
1035862330